文献速递糖尿病

过夜闭环控制改善成人1型糖尿病患者的血糖控制:一项多中心研究

Overnight Closed-Loop Control Improves Glycemic Control in a Multicenter Study of Adults With Type 1 Diabetes.
PubMed 文献 · J Clin Endocrinol Metab · 2017-01-01

这项随机交叉多中心试验纳入44例使用胰岛素泵的1型糖尿病患者,比较居家传感器增强泵治疗(SAP)与在受监督门诊环境中5晚过夜闭环控制(CLC,23:00至07:00)的血糖控制。40例完成研究,CLC较SAP显著增加24小时目标范围(70至180 mg/dL)时间(78.3% vs 71.4%,P=0.003)并减少低血糖时间(<70 mg/dL,2.5% vs 4.3%,P=0.002);10例居家CLC子研究显示相似但未达显著的趋势。

要点

  • 过夜CLC较SAP显著增加24小时目标范围时间(78.3% vs 71.4%,P=0.003)。
  • 过夜CLC较SAP显著减少24小时低血糖时间(<70 mg/dL,2.5% vs 4.3%,P=0.002)。
  • 居家CLC子研究显示相似但未达显著的趋势(过夜目标范围75.2% vs 62.2%,P=0.07)。

核心结论

  • 在受监督门诊环境中,仅过夜CLC增加了24小时目标范围时间并减少了24小时低血糖范围时间。
  • 居家试点扩展研究显示相似但未达显著的趋势。

研究设计与样本

  • 随机交叉多中心临床试验,纳入44例需要胰岛素泵治疗的1型糖尿病受试者。
  • 干预为居家传感器增强泵治疗(SAP)对比在受监督门诊环境(研究用房或酒店)中5晚过夜CLC(23:00至07:00激活)。
  • 另设子研究:随后居家进行5晚CLC,涉及10例1型糖尿病受试者。
  • 40例受试者完成研究(年龄45.5±9.5岁;血红蛋白A1c 7.4%±0.8%)。

主要发现

  • 24小时目标范围(70至180 mg/dL)时间CLC组78.3% vs SAP组71.4%(P=0.003)。
  • 过夜目标范围(70至180 mg/dL)时间CLC组85.7% vs SAP组67.6%(P<0.001)。
  • 24小时低血糖范围(<70 mg/dL)时间CLC组2.5% vs SAP组4.3%(P=0.002)。
  • 过夜低血糖范围(<70 mg/dL)时间CLC组0.9% vs SAP组3.2%(P<0.001)。
  • 07:00平均血糖水平CLC组123.7 mg/dL vs SAP组145.3 mg/dL(P<0.001)。

局限性

  • 居家试点扩展研究显示相似但未达显著的趋势(过夜目标范围75.2% vs 62.2%,P=0.07)。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

CONTEXT: Closed-loop control (CLC) for the management of type 1 diabetes (T1D) is a novel method for optimizing glucose control, and strategies for individualized implementation are being developed. OBJECTIVE: To analyze glycemic control in an overnight CLC system designed to "reset" the patient to near-normal glycemic targets every morning. DESIGN: Randomized, crossover, multicenter clinical trial. PARTICIPANTS: Forty-four subjects with T1D requiring insulin pump therapy. INTERVENTION: Sensor-augmented pump therapy (SAP) at home vs 5 nights of CLC (active from 23:00 to 07:00) in a supervised outpatient setting (research house or hotel), with a substudy of 5 nights of CLC subsequently at home. MAIN OUTCOME MEASURE: The percentage of time spent in the target range (70 to 180 mg/dL measured using a continuous glucose monitor). RESULTS: Forty subjects (age, 45.5 ± 9.5 years; hemoglobin A1c, 7.4% ± 0.8%) completed the study. The time in the target range (70 to 180 mg/dL) significantly improved in CLC vs SAP over 24 hours (78.3% vs 71.4%; P = 0.003) and overnight (85.7% vs 67.6%; P < 0.001). The time spent in a hypoglycemic range (<70 mg/dL) decreased significantly in the CLC vs SAP group over 24 hours (2.5% vs 4.3%; P = 0.002) and overnight (0.9% vs 3.2%; P < 0.001). The mean glucose level at 07:00 was lower with CLC than with SAP (123.7 vs 145.3 mg/dL; P < 0.001). The substudy at home, involving 10 T1D subjects, showed similar trends with an increased time in target (70 to 180 mg/dL) overnight (75.2% vs 62.2%; P = 0.07) and decreased time spent in the hypoglycemic range (<70 mg/dL) overnight in CLC vs SAP (0.6% vs 3.7%; P = 0.03). CONCLUSION: Overnight-only CLC increased the time in the target range over 24 hours and decreased the time in hypoglycemic range over 24 hours in a supervised outpatient setting. A pilot extension study at home showed a similar nonsignificant trend.

来源:J Clin Endocrinol Metab,查看原文。版权归原作者所有。

引用

  1. Brown SA, Breton MD, Anderson SM, et al. Overnight Closed-Loop Control Improves Glycemic Control in a Multicenter Study of Adults With Type 1 Diabetes. J Clin Endocrinol Metab. 2017. PMID: 28666360. doi:10.1210/jc.2017-00556

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。